Market Place
Sourcing Support
Tetraphase deal done, La Jolla Pharmaceutical taps Larry Edwards as CEO
30 Jul 2020 //
ENDPTS
La Jolla Pharmaceutical Company to Acquire Tetraphase Pharmaceuticals, Inc.
24 Jun 2020 //
BUSINESSWIRE
Tetraphase Announces Receipt of Proposal from La Jolla Pharmaceutical Company
22 Jun 2020 //
BUSINESSWIRE
As it happened: A bidding war for an antibiotic maker in a market
05 Jun 2020 //
ENDPTS
Melinta Therapeutics to Acquire Tetraphase Pharmaceuticals
04 Jun 2020 //
BUSINESSWIRE
AcelRx Announces It Will Not Further Revise Its Offer to Acquire Tetraphase
03 Jun 2020 //
PRNEWSWIRE
Tetraphase Announces Receipt of Amended Melinta Proposal, to AcelRx
01 Jun 2020 //
BUSINESSWIRE
Tetraphase Announces Second Amendment to Merger Agreement with AcelRx
29 May 2020 //
BUSINESSWIRE
Tetraphase Announces Receipt of Amended Melinta Proposal, Notice to AcelRx
28 May 2020 //
BUSINESSWIRE
AcelRx Pharmaceuticals Announces Revised Merger Agreement with Tetraphase
27 May 2020 //
PRNEWSWIRE
Restructured Melinta now wants to buy fellow antibiotic maker Tetraphase
23 May 2020 //
ENDPTS
Tetraphase Announces Determination of Superior Offer and Notice to AcelRx
21 May 2020 //
BUSINESSWIRE
Tetraphase`s & AcelRx Pharma Enter into Definitive Merger Agreement
16 Mar 2020 //
BUSINESSWIRE
AcelRx Pharmaceuticals to Acquire Tetraphase Pharmaceuticals
16 Mar 2020 //
PRESS RELEASE
Tetraphase Pharmac Announces $17.5 Million of Financings Priced At-the-Market
23 Jan 2020 //
BUSINESS WIRE
Tetraphase Pharmaceuticals Announces Completion of $8M
01 Nov 2019 //
BUSINESSWIRE
Tetraphase`s Announces $8 M Registered Direct Offering Priced At-the-Market
30 Oct 2019 //
BUSINESSWIRE
Tetraphase Pharmaceuticals to Present XERAVA™ (Eravacycline) Data at IDWeek 2019
25 Sep 2019 //
BIOSPACE
Tetraphase to Present Data at the 29th European Congress Infectious Diseases
08 Apr 2019 //
BUSINESSWIFRE
Tetraphase Pharmaceuticals Presents Preclinical Data on TP-2846
03 Apr 2019 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.